Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arcellx, Autolus, Azura, Canaquest, Chimerix, Exelixis, Syntrix, UCB.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera. 

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Alto Neuroscience, Onward Medical, Sight Sciences, Vida Health.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amo, Avrobio, Axsome, Bio-Path, Boehringer, Ingelheim, Cytokinetics, Daiichi Sankyo, Eli Lilly, Eupraxia, Gilead, KSQ, Medicinova, Neurocrine, Novartis, Ocugen, Pharming, Prometheus, Rani, Replimune, UCB, Vor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Quanterix, Reveal Genomics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzheon, Biovie, Cassava, Celldex, Dragonfly, Editas, Gossamer, Imaginab, Kinarus, Leo, Medicinova, Mirati.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Altpep, Emulate.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Altpep, Emulate.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Atea, Biogen, Clover, Eisai, H. Lundbeck, Henlius, Intravacc, Kintor, Kira, Otsuka, Providence, Qilu, Qurient, Sorrento, Vaxxinity.